The Cooper Companies Rating Reiterated by JPMorgan Chase & Co. (COO)
The Cooper Companies (NYSE:COO)‘s stock had its “overweight” rating reiterated by JPMorgan Chase & Co. in a research note issued on Tuesday. They currently have a $150.00 price objective on the stock, down from their previous price objective of $176.00. JPMorgan Chase & Co.’s price objective would indicate a potential upside of 10.68% from the company’s current price.
A number of other firms have also recently commented on COO. Analysts at KeyCorp initiated coverage on shares of The Cooper Companies in a research note on Wednesday, April 9th. They set a “hold” rating on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of The Cooper Companies in a research note on Wednesday, April 9th. They now have a $137.00 price target on the stock. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $137.83.
Shares of The Cooper Companies (NYSE:COO) traded up 7.03% during mid-day trading on Tuesday, hitting $145.06. 1,409,432 shares of the company’s stock traded hands. The Cooper Companies has a 52 week low of $116.95 and a 52 week high of $145.34. The stock’s 50-day moving average is $132.8 and its 200-day moving average is $129.6. The company has a market cap of $6.954 billion and a price-to-earnings ratio of 22.48.
The Cooper Companies (NYSE:COO) last posted its quarterly earnings results on Thursday, June 5th. The company reported $1.64 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.60 by $0.04. The company had revenue of $412.30 million for the quarter, compared to the consensus estimate of $411.41 million. During the same quarter last year, the company posted $1.50 earnings per share. The Cooper Companies’s revenue was up 7.4% compared to the same quarter last year. Analysts expect that The Cooper Companies will post $6.88 EPS for the current fiscal year.
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units, CooperVision, Inc and CooperSurgical, Inc CooperVision is a global manufacturer providing products for contact lens wearers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.